We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
-12.28%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$334B
AUM Growth
-$65.4B
Cap. Flow
-$11.7B
Cap. Flow %
-3.51%
Top 10 Hldgs %
13.97%
Holding
7,016
New
146
Increased
2,663
Reduced
3,412
Closed
209

Sector Composition

Rank Sector Weight
1 Technology 12.53%
2 Healthcare 10.36%
3 Financials 9.14%
4 Consumer Discretionary 7.65%
5 Communication Services 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PAI
5226
Western Asset Investment Grade Income Fund
PAI
$113M
$169K ﹤0.01%
12,790
PR
5227
Permian Resources
PR
$17.8B
$169K ﹤0.01%
15,399
-345,244
-96% -$5.92M
FOCL
5228
EDAP TMS S.A.
FOCL
$229M
$168K ﹤0.01%
90,869
+10,324
+13% +$25.9K
SIEB icon
5229
Siebert Financial
SIEB
$66.7M
$168K ﹤0.01%
11,671
-3,468
-23% -$44.4K
GQRE icon
5230
FlexShares Global Quality Real Estate Index Fund
GQRE
$426M
$167K ﹤0.01%
3,003
-334
-10% -$19.5K
IRIX icon
5231
IRIDEX
IRIX
$14.3M
$167K ﹤0.01%
35,471
-6,653
-16% -$33.1K
APB
5232
DELISTED
Asia Pacific Fund
APB
$167K ﹤0.01%
14,635
-109
-0.7% -$1.34K
LCTX icon
5233
Lineage Cell Therapeutics
LCTX
$269M
$166K ﹤0.01%
181,454
-46,700
-20% -$71.5K
PHT
5234
DELISTED
Pioneer High Income Fund
PHT
$166K ﹤0.01%
20,723
-363
-2% -$3.11K
SNCR
5235
DELISTED
Synchronoss Technologies
SNCR
$166K ﹤0.01%
+3,015
New +$166K
ZLAB icon
5236
Zai Lab
ZLAB
$2.06B
$166K ﹤0.01%
7,131
-1,871
-21% -$34.7K
AC
5237
DELISTED
Associated Capital Group
AC
$165K ﹤0.01%
4,687
+370
+9% +$14.8K
SPRO icon
5238
Spero Therapeutics
SPRO
$67.7M
$164K ﹤0.01%
26,799
+12,775
+91% +$103K
GRTS
5239
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$164K ﹤0.01%
+10,604
New +$202K
AENZ
5240
DELISTED
Aenza S.A.A.
AENZ
$164K ﹤0.01%
17,636
+9,767
+124% +$90.3K
IOTS
5241
DELISTED
Adesto Technologies Corp
IOTS
$163K ﹤0.01%
37,202
-10,647
-22% -$50.9K
AGGE
5242
DELISTED
IQ Enhanced Core Bond U.S. ETF
AGGE
$163K ﹤0.01%
8,739
-385
-4% -$7.09K
VLU icon
5243
State Street SPDR S&P 1500 Value Tilt ETF
VLU
$752M
$162K ﹤0.01%
1,767
+25
+1% +$2.51K
AFH
5244
DELISTED
Atlas Financial Holdings, Inc. Ordinary Shares
AFH
$162K ﹤0.01%
20,093
+6,790
+51% +$64.9K
ARVN icon
5245
Arvinas
ARVN
$518M
$161K ﹤0.01%
+12,502
New +$198K
MRNS
5246
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$161K ﹤0.01%
14,028
-740
-5% -$15K
POPE
5247
DELISTED
Pope Resources Depositary Receipts of Limited Partnership Units
POPE
$161K ﹤0.01%
2,439
-2,100
-46% -$147K
HTGM
5248
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$160K ﹤0.01%
349
-167
-32% -$104K
TRPX
5249
DELISTED
Therapix Biosciences Ltd.
TRPX
$160K ﹤0.01%
49,338
+41,448
+525% +$240K
ROX
5250
DELISTED
Castle Brands, Inc.
ROX
$160K ﹤0.01%
187,274
+3,646
+2% +$3.35K

Similar funds

Morgan Stanley's Q4 2018 Portfolio in Review

As of Q4 2018, Morgan Stanley held 7,016 positions worth $334B, down 16% from $400B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Morgan Stanley withdrew a net $11.7B in Q4 2018, closing 209 positions and reducing 3,412 holdings. Its most notable exit was Praxair Inc, an estimated $398M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Morgan Stanley opened a new position in Linde worth $342M.

  • Morgan Stanley's largest Q4 2018 buy was Linde: 2,188,871 shares worth $342M.
  • Morgan Stanley added most to People Inc in Q4 2018, an estimated $558M increase.
  • Morgan Stanley's biggest Q4 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
  • Morgan Stanley fully exited Praxair Inc in Q4 2018, selling an estimated $398M.
  • Morgan Stanley's ten largest holdings make up 14% of its $334B portfolio in Q4 2018.
  • Morgan Stanley opened 146 new positions and closed 209 in Q4 2018.
  • Morgan Stanley's portfolio value fell 16% quarter-over-quarter to $334B.

Based on Morgan Stanley's 13F filing for Q4 2018, filed 14 Feb 2019.